Iconovo Investor Relations Material
Latest events
Investor Update
Iconovo
Access the full event backlog
Slides, Transcripts, and Reports from 13,000 public companies
Latest reports from Iconovo
Access all reports
Iconovo AB develops and licenses inhalation devices for inhaled medicine. The company’s product portfolio includes the Icon, a disposable handheld inhaler, which is a solution for respiratory diseases; Clickhaler, a drug delivery inhaler that is used to treat respiratory airways inflammation and asthma; and Easyhaler, a powder inhaler that is used for the treatment of asthma and chronic obstructive pulmonary disease.
Latest articles
)
Pershing Square Capital Management: Conviction, Reinvention, and Contrarian Investing
Pershing Square Capital Management has grown into a top-tier hedge fund through reinvention, conviction, and focus on long-term value creation.
2 Jul 2025
)
Eli Lilly: The Pharma Giant Behind Mounjaro and Zepbound
Eli Lilly's journey from insulin pioneer to global pharma giant, leading innovation in diabetes, obesity, and the future of metabolic health.
30 Jun 2025
)
500 Years of Craft, One Family Legacy: Beretta Holding's Global Expansion
How Beretta Holding managed to transform from a 16th-century gun barrel producer into a global industrial group while preserving 500 years of legacy.
27 Jun 2025
Ticker symbol
ICO
Country
🇸🇪 Sweden